Partner Content Partner Content The 10th Annual RNA Therapeutics Returns to London this Feb! RNA Therapeutics
Partner Content Partner Content A Run Down of Keynote Sessions for Cell & Gene Therapy 2... Cell and Gene Therapy
Partner Content Partner Content Queen's University Belfast and Santen to Present Opening Key... Ophthalmic Drugs Conference London
Partner Content Hear from HealthTech Healx which raised $10m to accelerate d... SMi Reports: AI HealthTech Company Healx, who raised $10m to advance drug dis
Partner Content Partner Content Industry news with an exclusive interview by from Aerie Phar... Ophthalmic Drugs
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
